As you continue, thestudycorp.com<\/a> has the top and most qualified writers to help with any of your assignments. All you need to do is place an order <\/a>with us.<\/p>\n\n\n\n NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders<\/p>\n\n\n\n Photo Credit: Getty Images\/iStockphoto<\/small><\/p>\n\n\n\n Gastrointestinal (GI) and hepatobiliary disorders affect the structure and function of the GI tract. Many of these disorders often have similar symptoms, such as abdominal pain, cramping, constipation, nausea, bloating, and fatigue. Since multiple disorders can be tied to the same symptoms, it is important for advanced practice nurses to carefully evaluate patients and prescribe a treatment that targets the cause rather than the symptom.<\/p>\n\n\n\n Once the underlying cause is identified, an appropriate drug therapy plan can be recommended based on medical history and individual patient factors. In this Assignment, you examine a case study of a patient who presents with symptoms of a possible GI\/hepatobiliary disorder, and you design an appropriate drug therapy plan.<\/p>\n\n\n\n Write<\/strong> a 1-page paper that addresses the following:<\/p>\n\n\n\n Reminder: The College of Nursing requires that all papers<\/a> submitted include a title page, introduction, summary, and references. The Sample Paper provided at the Walden Writing Center offers an example of those required elements (available at http:\/\/writingcenter.waldenu.edu\/57.htm<\/a>). All papers submitted must use this formatting.<\/p>\n\n\n\n To submit your completed Assignment for review and grading, do the following:<\/strong><\/p>\n\n\n\n Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders<\/strong><\/p>\n\n\n\n Abdominal infections could be associated with a wide range of clinical features, including abdominal pain, nausea, vomiting, and diarrhea. In that regard, therefore, it would be easy to confuse one diagnosis over the other. This essay considers a patient HL case study presented with nausea, vomiting, diarrhea, the diagnosis made, and the treatment options are taken.<\/p>\n\n\n\n Diagnosis<\/strong><\/p>\n\n\n\n Hepatitis C is a possible diagnosis for HL. This condition would appear asymptomatic, but when symptoms occur, they could be mild or even severe. HL symptoms, including nausea, vomiting, and diarrhea, are prevalent with hepatitis C infection. This condition could be caused by viruses, bacteria, or parasitic infections. The infection can also be found in contaminated food or water, while chemical agents have also been shown to be causative. The diagnosis can be made using tests that include serologic assays, which measure the levels of antibodies that are generated, and the molecular assays which would detect the presence of HCV RNA (Chalasani et al., 2018).<\/p>\n\n\n\n Appropriate Drug Therapy Plan<\/strong><\/p>\n\n\n\n In this case study, the therapeutic options recommendable include Hepatitis C pegylated interferon-\u03b1 (IFN-\u03b1), administered weekly. Additionally, the patient is put on a daily dose of ribavirin for about 24 to 48 weeks. The combination is effective in clearing the HCV genotypes, especially 2 and 3 infections. The patient should also be put on food therapy. It is recommended that eating a frequent balanced diet possibly prevents nausea and vomiting associated with the disease. The balanced diet should be composed of cereals, whole grains, vegetables, and even fruits. There should also be a moderate to high protein diet to heal the infected liver tissue (Venugopal et al., 2018). The patient should also avoid certain drugs like aminoglycoside antibiotics, sedatives, and acetaminophen, which are considered hepatotoxic in high doses.<\/p>\n\n\n\n Appropriate use of the proper diagnostic approaches forms the basis of diagnosis, which informs the kind of intervention to be taken. Viruses, bacteria, and chemical agents can cause HCV. The condition can be treated using pegylated interferon-\u03b1 (IFN-\u03b1) and ribavirin.<\/p>\n\n\n\n References<\/strong><\/p>\n\n\n\n Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., \u2026 Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology<\/em>, 67<\/em>(1), 328\u2013357. https:\/\/doi.org\/10.1002\/hep.29367<\/p>\n\n\n\n Venugopal, V., Padmanabhan, P., Raja, R., & Dixit, N. M. (2018). Modelling how responsiveness to interferon improves interferon-free treatment of hepatitis C virus infection. PLoS Computational Biology<\/em>, 14<\/em>(7), e1006335. https:\/\/doi.org\/10.1371\/journal.pcbi.1006335<\/p>\n\n\n\n To access your rubric:<\/p>\n\n\n\n Week 4 Assignment Rubric<\/p>\n\n\n\n To check your Assignment draft for authenticity:<\/p>\n\n\n\n Submit your Week 4 Assignment draft and review the originality report.<\/p>\n\n\n\n To participate in this Assignment:<\/p>\n\n\n\n Week 4 Assignment<\/p>\n\n\n\n Photo Credit: [BrianAJackson]\/[iStock \/ Getty Images Plus]\/Getty Images<\/small><\/p>\n\n\n\n In the next module, <\/strong>you will examine types of drugs prescribed to patients with endocrine disorders, such as diabetes, and you will consider the impact of patient factors on the effects of these drugs.<\/p>\n\n\n\n To go to the next week:<\/p>\n\n\n\n Module 4<\/p>\n\n\n\n Symptoms of various gastrointestinal (GI) and hepatobiliary disorders often overlap, making diagnosis and treatment challenging. For example, symptoms such as vomiting, constipation, and bloating are non-specific and could also be the result of underlying medical history or current prescription drug use. As an advanced practice nurse, you could be potentially responsible for providing care to a patient who may present with non-specific symptoms related to the gastrointestinal and hepatobiliary systems.<\/p>\n\n\n\n How would you proceed to care for this patient? What type of drug therapy might you recommend, not knowing current medical history or prescription drug use? Are there certain drugs you should avoid in ensuring a drug-drug interaction does not occur? These are the types of questions that may guide you in your role as an advanced practice nurse.<\/p>\n\n\n\n Module 3:\u00a0Gastrointestinal and Hepatobiliary Systemsis a 1-week module, Week 4 of the course. In this module, you will examine diagnoses for patients with potential GI and hepatobiliary disorders. You also develop a drug therapy plan based on patient history and diagnosis.<\/p>\n\n\n\n As you continue, thestudycorp.com<\/a> has the top and most qualified writers to help with any of your assignments. All you need to do is place an order <\/a>with us. (Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders)<\/p>\n\n\n\n As an advanced practice nurse, you will likely encounter patients who will present with symptoms affecting the gastrointestinal (GI) tract. Of special note, is the consideration that most symptoms concerning the GI tract are non-specific and therefore, diagnosing diagnoses of the GI tract require thoughtful and careful investigation. Similarly, hepatobiliary disorders may also mirror many of the signs and symptoms that patients present when suffering from GI disorders.<\/p>\n\n\n\n How might you tease out the specific signs and symptoms between these potential disorders and body systems? What drug therapy plans will best address these disorders for your patients?<\/p>\n\n\n\n This week, you examine GI and hepatobiliary disorders. You will review a patient case study and consider those factors in recommending and prescribing a drug therapy plan fo your patient.<\/p>\n\n\n\n Students will:<\/strong><\/p>\n\n\n\n Required Readings<\/strong> (click to expand\/reduce)<\/p>\n\n\n\n Rosenthal, L. D., & Burchum, J. R. (2021). Lehne\u2019s pharmacotherapeutics for advanced practice nurses and physician assistants <\/em>(2nd<\/sup> ed.) St. Louis, MO: Elsevier.<\/p>\n\n\n\n Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1)<\/em>, 328\u2013357. Retrieved from https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.29367<\/p> <\/p> This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.<\/p><\/blockquote>\n\n\n\n As an advanced practice nurse, you will likely encounter patients who will present with symptoms affecting the gastrointestinal (GI) tract. Of special note, is the consideration that most symptoms concerning the GI tract are non-specific and therefore, diagnosing diagnoses of the GI tract require thoughtful and careful investigation. Similarly, hepatobiliary disorders may also mirror many of the signs and symptoms that patients present when suffering from GI disorders.<\/p>\n\n\n\n How might you tease out the specific signs and symptoms between these potential disorders and body systems? What drug therapy plans will best address these disorders for your patients?<\/p>\n\n\n\n This week, you examine GI and hepatobiliary disorders. You will review a patient case study and consider those factors in recommending and prescribing a drug therapy plan for your patient.<\/p>\n\n\n\n As you continue, thestudycorp.com<\/a> has the top and most qualified writers to help with any of your assignments. All you need to do is place an order <\/a>with us. (Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders)<\/p>\n\n\n\n Students will:<\/strong><\/p>\n\n\n\n Required Readings<\/strong> (click to expand\/reduce)<\/p>\n\n\n\n Rosenthal, L. D., & Burchum, J. R. (2021). Lehne\u2019s pharmacotherapeutics for advanced practice nurses and physician assistants <\/em>(2nd<\/sup> ed.) St. Louis, MO: Elsevier.<\/p>\n\n\n\n Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., . . . Sanya, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1)<\/em>, 328\u2013357. Retrieved from https:\/\/aasldpubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hep.29367<\/p> <\/p> This article details the diagnosis and management of nonalcoholic fatty liver disease. Review this article to gain an understanding of the underlying pathophysiology as well as the suggested pharmacotherapeutics that might be recommended to treat this disorder.<\/p><\/blockquote>\n\n\n\n Rubric Detail<\/p>\n\n\n\n Select Grid View or List View to change the rubric\u2019s layout.<\/p>\n\n\n\n Name: NURS_6521_Week4_Assignment_Rubric The response includes specific, accurate, and detailed examples that fully support the justification provided. As you continue, thestudycorp.com<\/a> has the top and most qualified writers to help with any of your assignments. All you need to do is\u00a0place an order\u00a0<\/a>with us. (Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders)<\/p>\n\n\n\n The response includes only 1-2 examples that fully support the justification provided. The response may include examples, which may inaccurately or vaguely support the justification provided. The response does not include examples that support the justification provided, or is missing.NURS 6521 Assignment: Pharmacotherapy for Gastrointestinal and Hepatobiliary Disorders<\/h2>\n\n\n\n
![\"\"](\"https:\/\/class.content.laureate.net\/04b07aa64ac7307392ebf1d09c3e1933.jpg\" "\\"\\"")
<\/figure>\n\n\n\nTo Prepare<\/h5>\n\n\n\n
By Day 7 of Week 4<\/h5>\n\n\n\n
Submission and Grading Information<\/h3>\n\n\n\n
Grading Criteria<\/h5>\n\n\n\n
Check Your Assignment Draft for Authenticity<\/h5>\n\n\n\n
Submit Your Assignment by Day 7 of Week 4<\/h5>\n\n\n\n
\n\n\n\nWhat\u2019s Coming Up in Module 4?<\/h2>\n\n\n\n
![\"\"](\"https:\/\/class.content.laureate.net\/7a53069e2d89c636350ca4058b93b2aa.jpg\" "\\"\\"")
<\/figure>\n\n\n\nNext Week<\/h4>\n\n\n\n
Module 3: Gastrointestinal and Hepatobiliary Systems<\/h2>\n\n\n\n
What\u2019s Happening This Module?<\/h3>\n\n\n\n
![\"Pharmacotherapy](\"https:\/\/privateessaywriters.com\/wp-content\/uploads\/2022\/01\/order-1024x334.jpg\" "\\"\\"")
Week 4: Gastrointestinal and Hepatobiliary Disorders<\/h2>\n\n\n\n
Learning Objectives<\/h3>\n\n\n\n
\n\n\n\nLearning Resources<\/h2>\n\n\n\n
Week 4: Gastrointestinal and Hepatobiliary Disorders<\/h2>\n\n\n\n
Learning Objectives<\/h3>\n\n\n\n
Learning Resources<\/h2>\n\n\n\n
Grid View
List View
Excellent Good Fair Poor
Explain your diagnosis for the patient, including your rationale for the diagnosis.
23 (23%) \u2013 25 (25%)
The response accurately and clearly explains in detail the diagnosis for the patient, including an accurate and thorough rationale for the diagnosis that supports clinical judgment.
20 (20%) \u2013 22 (22%)
The response provides a basic explanation of 1-2 diagnoses for the patient, including an accurate rationale for the diagnosis that may support clinical judgment.
18 (18%) \u2013 19 (19%)
The response inaccurately or vaguely explains the diagnosis for the patient, including an inaccurate or vague rationale for the diagnosis that may or may not support clinical judgment.
0 (0%) \u2013 17 (17%)
The response inaccurately and vaguely explains the diagnosis for the patient, including an inaccurate and vague rationale for the diagnosis that does not support clinical judgment, or is missing.
Describe an appropriate drug therapy plan based on the patient\u2019s history, diagnosis, and drugs currently prescribed.
27 (27%) \u2013 30 (30%)
The response accurately and completely describes in detail an appropriate drug therapy plan based on the patient\u2019s history, diagnosis, and drugs currently prescribed.
24 (24%) \u2013 26 (26%)
The response describes a basic explanation of the appropriate drug therapy plan based on the patient\u2019s history, diagnosis, and drugs currently prescribed.
21 (21%) \u2013 23 (23%)
The response inaccurately or vaguely describes an appropriate drug therapy plan based on the patient\u2019s history, diagnosis, and drugs currently prescribed.
0 (0%) \u2013 20 (20%)
The response inaccurately and vaguely describes an appropriate drug therapy plan based on the patient\u2019s history, diagnosis, and drugs currently prescribed.
Justify why you would recommend this drug therapy plan for this patient. Be specific and provide examples.
27 (27%) \u2013 30 (30%)
The response provides an accurate, clear, and detailed justification for the recommended drug therapy plan for this patient.<\/p>\n\n\n\n
24 (24%) \u2013 26 (26%)
The response provides a basic justification for the recommended drug therapy plan for this patient.<\/p>\n\n\n\n
21 (21%) \u2013 23 (23%)
The response provides an inaccurate or vague justification for the recommended drug therapy plan for this patient.<\/p>\n\n\n\n
0 (0%) \u2013 20 (20%)
The response provides an inaccurate and vague justification for the recommended drug therapy plan for this patient, or is missing.<\/p>\n\n\n\n
Written Expression and Formatting \u2013 Paragraph Development and Organization:
Paragraphs make clear points that support well developed ideas, flow logically, and demonstrate continuity of ideas. Sentences are carefully focused\u2013neither long and rambling nor short and lacking substance.
5 (5%) \u2013 5 (5%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity.
4 (4%) \u2013 4 (4%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 80% of the time.
3.5 (3.5%) \u2013 3.5 (3.5%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity 60%\u201379% of the time.
0 (0%) \u2013 3 (3%)
Paragraphs and sentences follow writing standards for flow, continuity, and clarity less than 60% of the time.
Written Expression and Formatting \u2013 English writing standards:
Correct grammar, mechanics, and proper punctuation
5 (5%) \u2013 5 (5%)
Uses correct grammar, spelling, and punctuation with no errors
4 (4%) \u2013 4 (4%)
Contains a few (1\u20132) grammar, spelling, and punctuation errors
3.5 (3.5%) \u2013 3.5 (3.5%)
Contains several (3\u20134) grammar, spelling, and punctuation errors
0 (0%) \u2013 3 (3%)
Contains many (\u2265 5) grammar, spelling, and punctuation errors that interfere with the reader\u2019s understanding
Written Expression and Formatting \u2013 The paper follows correct APA format for title page, headings, font, spacing, margins, indentations, page numbers, running head, parenthetical\/in-text citations, and reference list.
5 (5%) \u2013 5 (5%)
Uses correct APA format with no errors
4 (4%) \u2013 4 (4%)
Contains a few (1\u20132) APA format errors
3.5 (3.5%) \u2013 3.5 (3.5%)
Contains several (3\u20134) APA format errors
0 (0%) \u2013 3 (3%)
Contains many (\u2265 5) APA format errors
Total Points: 100
Name: NURS_6521_Week4_Assignment_Rubric<\/p>\n\n\n\nRead More:<\/strong><\/h2>\n\n\n\n